Karl Fredrik Sjövall
Chairman bei ZICCUM AB
Profil
Karl Fredrik Sjövall currently works at Lipidor AB, as Chairman from 2020, Monivent AB, as Chairman from 2019, Ziccum AB, as Chairman from 2022, Emollivet AB, as Chairman, Axelero AB, as Director from 2009, and Phargentis AB, as Director.
Mr. Sjövall also formerly worked at Promore Pharma AB, as Chief Executive Officer & Managing Director, PharmaSurgics In Sweden AB, as Chief Executive Officer, Inhalation Sciences Sweden AB, as Chief Executive Officer, Bio Vitos Pharma AB, as Chief Executive Officer & Director in 2015, Ectin Research AB, as Chairman, and Biosergen AS, as Manager-Business Development.
Mr. Sjövall received his graduate degree from Chalmers University of Technology.
Aktive Positionen von Karl Fredrik Sjövall
| Unternehmen | Position | Beginn |
|---|---|---|
| ZICCUM AB | Chairman | 05.04.2017 |
| LIPIDOR AB | Chairman | 01.01.2020 |
| MONIVENT AB | Chairman | 01.05.2019 |
| Axelero AB | Director/Board Member | 01.10.2009 |
| Emollivet AB | Chairman | - |
| Phargentis AB | Director/Board Member | - |
Ehemalige bekannte Positionen von Karl Fredrik Sjövall
| Unternehmen | Position | Ende |
|---|---|---|
| ECTIN RESEARCH AB | Chairman | - |
| BIO VITOS PHARMA AB | Chief Executive Officer | - |
| INHALATION SCIENCES SWEDEN AB | Chief Executive Officer | - |
| ░░░░░░░ ░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
| ░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Karl Fredrik Sjövall
| Chalmers University of Technology | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| LIPIDOR AB | Commercial Services |
| INHALATION SCIENCES SWEDEN AB | Health Technology |
| BIO VITOS PHARMA AB | Health Technology |
| MONIVENT AB | Health Technology |
| ZICCUM AB | Health Technology |
| ECTIN RESEARCH AB | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Biosergen AS
 Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Health Technology |
Promore Pharma AB
 Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Health Technology |
PharmaSurgics In Sweden AB
 PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology PharmaSurgics is a clinical stage biotech company developing novel treatments for the prevention of harmful scarring (adhesions) after surgery. Post-surgical adhesions develop in millions of patients every year and are a source of great patient suffering and enormous healthcare expenditures. The company was founded in 2005 after extensive research done by Dr Inger Mattsby-Baltzer, PhD and Professor Kjell Olmarker MD, PhD at the Sahlgrenska Academy. PharmaSurgics is based in Göteborg, Sweden, where comprehensive in vitro and in vivo facilities have been established. | Health Technology |
| Axelero AB | |
| Emollivet AB | |
| Phargentis AB |
